GlassScriptPhysician profile
Abraham Abdemur
NPI 1932559085
$3,353.39
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,901 · 2021: $323 · 2022: $130.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,859.00 | 2020 | |
| Biogen, INC. | $168.67 | 2021-2022 | |
| Allergan, INC. | $125.00 | 2021 | |
| Daiichi Sankyo INC. | $64.89 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $29.87 | 2021 | |
| Grt US Holding, INC. | $28.00 | 2021 | |
| Argenx US, INC. | $23.11 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.85 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Abdemur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.